MedPath

A Low Dose Dexmedetomidine in Sedation Colonoscopy

Not Applicable
Not yet recruiting
Conditions
Colonoscopy
Interventions
Registration Number
NCT06208956
Lead Sponsor
West China Hospital
Brief Summary

104 patients who undergo painless colonoscopy from January 20,2024 to February 29,2024 will be randomized to two groups: propofol group and dexmedetomidine group.

In the dexmedetomidine group,dexmedetomidine is infusion intravenously with a loading dose of 0.5 μg kg-1 for 10 min, then infusion at 0.3 μg kg-1 h-1 according to the ideal body weight of the patient until the end of colonoscopy. In the propofol group, Propofol is administrated 1 mg kg-1 intravenously, then titrated given by 0.5 mg kg-1 during the whole process.

Detailed Description

104 patients who undergo painless colonoscopy from January 20,2024 to February 29,2024 will be randomized to two groups: propofol group and dexmedetomidine group.

In the dexmedetomidine group,dexmedetomidine is infusion intravenously with a loading dose of 0.5 μg kg-1 for 10 min, then infusion at 0.3 μg kg-1 h-1 according to the ideal body weight of the patient until the end of colonoscopy. In the propofol group, Propofol is administrated 1 mg kg-1 intravenously, then titrated given by 0.5 mg kg-1.For all patients, if Ramsay sedation scale score reach 3, colonoscope will be inserted. During the whole process, maintenance Ramsay score of 3 to 4. Propofol 10 mg will be administrated as the rescue dose if body movement occur during colonoscopy.

The primary outcome is the occurrence of hypotension. Key secondary outcomes are time-weighted average (TWA), area under the threshold (AUT) and cumulative duration of hypotension, as well as the maximum reduction in BP. Other secondary outcomes include(1) the incidence of bradycardia, hypoxemia or body movement;(2) discharge time (from the end of colonoscopy to discharge); (3) patients and endoscopists' satisfaction score (using an 11-point Likert scale, with 0 indicating "very dissatisfied" and 10 indicating "very satisfied"); (4) the incidence of dizziness, fatigue, or nausea and vomiting

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
104
Inclusion Criteria
  1. Patients aged above 18 years
  2. American Society of Anesthesiologists (ASA) physical status of 1-2
  3. Patients scheduled for sedation colonoscopy
Exclusion Criteria
  1. Emergency patients
  2. Body weight < 40 kg or >100 kg
  3. Allergy to dexmedetomidine, propofol in this trail, a previous adverse reaction to dexmedetomidine or propofol
  4. Pregnancy or lactation
  5. Drug abusers
  6. Participation in other clinical studies within the previous 3 months
  7. renal impairment (glomerular filtration rate < 60 ml/min), significant hepatic impairment (ascites, cirrhosis, or with international normalized ratio(INR) >1.5)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dexmedetomidine groupDexmedetomidineDexmedetomidine is infusion intravenously with a loading dose of 0.5 μg kg-1 for 10 min, then infusion at 0.3 μg kg-1 h-1 according to the ideal body weight of the patient until the end of colonoscopy. If Ramsay sedation scale score reach 3, colonoscope will be inserted. During the whole process, maintenance Ramsay score of 3 to 4. Propofol 10 mg will be administrated as the rescue dose if body movement occur during colonoscopy.
Propofol groupPropofolPropofol is administrated 1 mg kg-1 intravenously, then titrated given by 0.5 mg kg-1 until Ramsay score reach 3. During the whole process, propofol is given intermittently to maintain Ramsay score 3 to 4. If body movement happen, propofol 10mg will be administrated every time.
Primary Outcome Measures
NameTimeMethod
The primary outcome is the incidence of hypotensionThe time during colonoscopy, an average of 15 minutes

Hypotension is defined as 20% decrease from baseline systolic blood pressure (SBP) or diastolic blood pressure (DBP), or SBP \< 90, and/or DBP \< 50 mmHg

Secondary Outcome Measures
NameTimeMethod
Time-weighted average (TWA)The time during colonoscopy, an average of 15 minutes

TWA is calculated as the AUT divided by the total duration of colonoscopy

The incidence of hypoxemiaThe time during colonoscopy, an average of 15 minutes

Hypoxemia is defined as oxygen saturation (SpO2)\<90%

Maximum reduction in blood pressure (BP)The time during colonoscopy, an average of 15 minutes

Maximum reduction in systolic blood pressure (SBP) ,diastolic blood pressure (DBP) and mean arterial pressure (MAP) from baseline

The incidence of bradycardiaThe time during colonoscopy, an average of 15 minutes

Bradycardia is defined as heat rate(HR) \<50 beats/min

Area under the threshold (AUT) of hypotensionThe time during colonoscopy, an average of 15 minutes

AUT=depth of hypotension below (a 20% decrease in baseline SBP or DBP) or (90 mm Hg of SBP or 50 mm Hg of DBP)× time in minutes spent of hypotension. As an example, a patient undergoes colonoscopy that lasts 15 min, in which he experiences 2 episodes of hypotension, all lasting for 1 min and all with a minimal SBP of 80 mm Hg. The AUT = 2 min × (90 -80= 10 mm Hg under the SBP threshold of 90 mm Hg) = 2×10 = 20 mm Hg per minute.

Cumulative duration of hypotensionThe time during colonoscopy, an average of 15 minutes

The total time of patients experience hypotenion(hpotension defined as 20% decrease from baseline systolic blood pressure (SBP) or diastolic blood pressure (DBP), or SBP \< 90, and/or DBP \< 50 mmHg)

The body movementThe time during colonoscopy, an average of 15 minutes

The twisting of the patient's body due to the stimulation of the colonoscopy, making it difficult to proceed with the procedure

Discharge timeFrom the end of colonoscopy to discharge,an average of 40 minutes

From the end of colonoscopy to discharge

Patients satisfaction scoreWhen the patient is fully awake after colonoscopy,an average of 5 minutes

Using an 11-point Likert scale, with 0 indicating "very dissatisfied" and 10 indicating "very satisfied"

Endoscopists'satisfaction scoreAt the end of colonoscopy,an average of 15 minutes

Using an 11-point Likert scale, with 0 indicating "very dissatisfied" and 10 indicating "very satisfied"

The incidence of dizzinessFrom the end of colonoscopy to discharge,an average of 40 minutes

The investigators consider it dizziness if patients fell any dizziness

The incidence of nausea and vomitingFrom the end of colonoscopy to discharge,an average of 40 minutes

The investigators consider it nausea and vomiting if patients fell any nausea and vomiting

The incidence of fatigueFrom the end of colonoscopy to discharge,an average of 40 minutes

The investigators consider it fatigue if patients fell any fatigue

© Copyright 2025. All Rights Reserved by MedPath